Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
OSH 1 LIQUIDATING Corp (OSH)
|
Add to portfolio |
|
|
|
| Price: |
$60.28
| | Metrics |
| OS: |
8.6
|
k
| |
|
|
| Market cap: |
$521.1
|
k
| |
10
|
% ROIC
|
|
Net debt:
|
$510
|
M
| |
6.1
|
x Debt/EBITDA
|
|
EV:
|
$511
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$83.9
|
M
| |
6.1
|
x EV/EBITDA
|
|
EBIT
|
$51.4
|
M
| |
9.9
|
x EV/EBIT
|
| EPS |
($19.64)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
| Date Filed | Type | Description |
| 03/16/2021 |
GN
| CEO's of Hologic, Empower Clinics, Oak Street Health, and Reliq Health Technologies - Positioning For Post-Pandemic Healthcare Boom Ahead |
| 12/03/2020 |
GN
| Leading the $2.8 Trillion US Healthcare Market: CEO's of Oak Street Health, Skylight Health, 1life Healthcare and Teladoc - Driving Explosive Revenue Gro...
|
| 10/08/2020 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oak Street Health, Inc. - OSH |
| 09/30/2020 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oak Street Health, Inc. - OSH |
| 09/27/2020 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oak Street Health, Inc. - OSH |
| 02/27/2014 |
8-K
| Bankruptcy or Receivership, Material Modifications to Rights of Security Holders, Departure of Directors or Certain Officers;... |
| 02/14/2014 |
SC 13G/A
| Eddie Lampert reports a 0% stake in OSH 1 Liquidating Corporation |
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Feb-02-13 | Jan-28-12 | Jan-29-11 | Jan-30-10 |
| Revenues | 657.3 | 660.5 | 660.7 | 682.4 |
| Revenue growth | -0.5% | 0.0% | -3.2% | |
| Cost of goods sold | 450.9 | 441.0 | 431.8 | 438.1 |
| Gross profit | 206.5 | 219.4 | 228.9 | 244.3 |
| Gross margin | 31.4% | 33.2% | 34.6% | 35.8% |
| Selling, general and administrative | 187.7 | 173.7 | 165.7 | 165.6 |
| EBITA | -7.6 | 25.2 | 40.6 | 48.8 |
| EBITA margin | -1.2% | 3.8% | 6.1% | 7.2% |
| Amortization of intangibles | 6.1 | 8.8 | 8.6 | |
| EBIT | -13.7 | 16.4 | 32.0 | 48.8 |
| EBIT margin | -2.1% | 2.5% | 4.8% | 7.2% |
| Pre-tax income | -149.9 | -25.3 | 14.3 | 32.1 |
| Income taxes | -31.5 | -10.8 | 5.6 | 12.7 |
| Tax rate | 21.0% | 42.8% | 39.0% | 39.8% |
| Net income | -118.4 | -14.5 | 8.7 | 19.3 |
| Net margin | -18.0% | -2.2% | 1.3% | 2.8% |
| |
| Diluted EPS | ($19.65) | ($2.40) | $1.45 | $3.21 |
| Shares outstanding (diluted) | 6.0 | 6.0 | 6.0 | 6.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|